Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Samsung Medical Center
Samsung Medical Center
Centre Hospitalier Régional d'Orléans
Weill Medical College of Cornell University
University of Pittsburgh
Corcept Therapeutics
Centre Hospitalier Universitaire de Liege
Corcept Therapeutics